Pharmacy
News
Obinutuzumab approved for CLL in Europe
Obinutuzumab can now be used in combination with chlorambucil to treat patients with previously untreated chronic lymphocytic leukemia (CLL) who...
News
Apixaban gets European approval for DVT, PE
Credit: Kevin MacKenzie The European Commission has approved apixaban (Eliquis) to treat and prevent deep vein thrombosis (DVT) and pulmonary...
News
FDA expands approved use of ibrutinib in CLL
Credit: Steven Harbour The US Food and Drug Administration (FDA) has expanded the approved use of ibrutinib (Imbruvica) in patients with chronic...
News
CHMP recommends ibrutinib for CLL, MCL
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) is recommending marketing authorization for ibrutinib (...
News
CHMP recommends idelalisib for CLL, FL
Days after gaining approval for 3 indications in the US, idelalisib (Zydelig) has earned a positive opinion from the European Medicine Agency’s...
News
BI denies allegations about dabigatran
Credit: CDC A series of papers published in The BMJ have raised concerns about the anticoagulant dabigatran (Pradaxa). The papers claim the...
News
FDA approves idelalisib for CLL, SLL and FL
The drug was granted traditional approval for use in combination with rituximab to treat patients with relapsed CLL who cannot receive rituximab...
News
NICE expands recommended use for prasugrel
Credit: Mass.
News
Drug approved to treat NHL in Israel
The Israeli Ministry of Health has granted approval for the antineoplastic agent pixantrone (Pixuvri). The drug is now approved as monotherapy...
News
FDA warns public of non-sterile products
Credit: Bill Branson The US Food and Drug Administration (FDA) is alerting healthcare professionals and consumers not to use sterile drugs...
News
FDA approves product to treat attacks in HAE
The US Food and Drug Administration (FDA) has approved the first recombinant C1-esterase inhibitor product (Ruconest) for the treatment of acute...